SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-118989
Filing Date
2020-10-28
Accepted
2020-10-28 16:46:36
Documents
58
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inva-20200930x10q.htm   iXBRL 10-Q 1687020
2 EXHIBIT 31.1 inva-20200930xex31d1.htm EX-31.1 8755
3 EXHIBIT 31.2 inva-20200930xex31d2.htm EX-31.2 9656
4 EXHIBIT 32 inva-20200930xex32.htm EX-32 14005
  Complete submission text file 0001104659-20-118989.txt   6396959

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA inva-20200930.xsd EX-101.SCH 36638
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inva-20200930_cal.xml EX-101.CAL 63541
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inva-20200930_def.xml EX-101.DEF 147319
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20200930_lab.xml EX-101.LAB 359196
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20200930_pre.xml EX-101.PRE 278361
10 EXTRACTED XBRL INSTANCE DOCUMENT inva-20200930x10q_htm.xml XML 1271312
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 201269242
SIC: 2834 Pharmaceutical Preparations